What You Should Know about Home Projectors
TINA.org sheds light on confusing and misleading brightness claims.
XanRelax and Addall
Case Name (Date)
Brown et al. v. ZMB Enterprises LLC
22-cv-54, S.D. Cal.
(Jan. 2022)
Product/Service
XanRelax and Addall
Allegations
Misleadingly labeling products as “dietary supplements” when they contain illegal ingredients and thus do not meet the definition of “dietary supplement” under federal law
Misleadingly using the name XanRelax to make consumers believe the product provides benefits similar to the prescription drug Xanax
Misleadingly using the name Addall to make consumers believe the product provides benefits similar to the prescription drug Adderall
Falsely marketing products as able to treat, cure, and prevent diseases, including depression, anxiety, and ADHD, and without FDA approval to do so
Status
Pending
The Latest
Under The Influence: Prediction Markets Are Harnessing Modern Joe Camels
Brant James, Ingame
Forever Living Ditching MLM Model
Company becomes the latest to leave the industry.
Fixing the Subscription Trap
The FTC’s Negative Option Rule do-over – and what’s at stake.
A Brand Story
Be wary of questionable and deceptive claims in origin stories.